Albert David Ltd Reports Net Loss of ₹1.49 Cr in FY26, Proposes Dividend

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Albert David Ltd Reports Net Loss of ₹1.49 Cr in FY26, Proposes Dividend

Albert David Ltd reported a net loss of ₹1.49 crore for FY26, a significant drop from the previous year's profit of ₹17.20 crore. Revenue also saw a slight decline. The company proposed a ₹5 per share dividend.

Albert David Ltd Reports ₹1.49 Crore Net Loss for FY26, Recommends Dividend

Albert David Ltd has reported a net loss of ₹1.49 crore for the financial year 2025-26. This marks a significant shift from the profit of ₹17.20 crore recorded in the previous fiscal year. Revenue from operations also saw a slight decrease.

Reader Takeaway: Net loss reported; dividend proposed despite profitability challenges.

What just happened

Albert David Ltd's financial results for the fiscal year 2025-26 indicate a challenging period. The company posted a net loss of ₹1.49 crore, a stark contrast to the net profit of ₹17.20 crore in FY25. Revenue from operations slightly decreased to ₹333.60 crore from ₹345.77 crore.

Why this matters

The shift to a net loss raises concerns about the company's operational efficiency and market performance. A decline in Profit Before Tax (PBT) from ₹25.23 crore to ₹0.52 crore highlights significant pressure on its profit margins. Despite the loss, the board has proposed a final dividend of ₹5.00 per equity share, signaling a commitment to shareholders.

The backstory

The company's financial performance in FY25 showed a healthy profit. However, FY26 results reveal a downturn. Finance costs saw a notable increase, rising to ₹2.63 crore from ₹0.41 crore in the prior year, contributing to the reduced profitability.

What changes now

The company has seen leadership changes. Mr. Amit Mahla was appointed CEO effective May 12, 2026, and later as Whole-time Director & CEO from June 19, 2026. This transition follows the resignation of the former Managing Director & CEO, Mr. Umesh Manohar Kunte, on December 18, 2025. The new leadership is expected to steer the company's strategy, potentially focusing on its Placentrex portfolio for growth.

Risks to watch

The primary risk for Albert David Ltd is its inability to return to profitability. The negative Return on Net Worth of -0.38% in FY26, compared to 6.27% in FY25, indicates reduced efficiency in generating returns on equity. Sustaining operations and market share will be crucial.

Peer comparison

Albert David Ltd operates in the pharmaceutical sector. While specific peer financial data for FY26 is not provided in the filing, the company's shift to a loss contrasts with potentially stable or growing performances of other players in the industry, depending on their market segments and product portfolios.

Context metrics (time-bound)

For F.Y. 2025-26:

  • Revenue from operations: ₹333.60 crore
  • Net loss (PAT): ₹(1.49) crore
  • Profit Before Tax (PBT): ₹0.52 crore
  • Total expenses: ₹340.53 crore
  • Finance costs: ₹2.63 crore
  • Proposed Dividend: ₹5.00 per share

For F.Y. 2024-25:

  • Revenue from operations: ₹345.77 crore
  • Net profit (PAT): ₹17.20 crore
  • Profit Before Tax (PBT): ₹25.23 crore
  • Total expenses: ₹350.12 crore
  • Finance costs: ₹0.41 crore

What to track next

Investors will be closely watching the strategies implemented by the new CEO, Mr. Amit Mahla, to improve the company's financial performance and return it to profitability. Monitoring cost management and revenue generation efforts will be key.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.